Share Email Print

Proceedings Paper

In vitro and in vivo evaluation of the induced PDT response using a femtosecond laser
Author(s): C. Grecco; C. Kurachi; V. S. Bagnato
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

One of the limitations of PDT in the treatment of bulk tumors is the light penetration in biological tissues at the red spectrum. PDT illumination at short pulsed regime may present a higher light penetration compared to the CW regime, and potentially a higher volume of induced necrosis. The major goal of this study was an in vitro and in vivo evaluation of PDT response after illumination using a 630 nm femtosecond laser. Photogem in distilled water solution was illuminated either with CW or femtosecond laser under the same fluence and fluence rate parameters. Wistar rats weighting between 280 and 300 g were intravenously photosensitized with Photogem. Thirty minutes after drug injection, the normal liver was irradiated either with the CW or the femtosecond laser (fluence: 150 J/cm2). The in vitro results showed that, under the same conditions, the degradation rate evaluated via fluorescence spectroscopy was higher under femtosecond laser irradiation. Histological analysis of the induced necrosis showed that there was a significant higher depth of necrosis when the femtosecond laser was used. Based on these results, femtosecond lasers seem to be an alternative in PDT applications, improving results for the treatment of lesions for which a larger light penetration is required.

Paper Details

Date Published: 13 July 2009
PDF: 6 pages
Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 73804Y (13 July 2009); doi: 10.1117/12.823021
Show Author Affiliations
C. Grecco, Univ. of São Paulo (Brazil)
C. Kurachi, Univ. of São Paulo (Brazil)
V. S. Bagnato, Univ. of São Paulo (Brazil)

Published in SPIE Proceedings Vol. 7380:
Photodynamic Therapy: Back to the Future
David H. Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?